InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Kalkofen Donald A., Chief Financial Officer. Director active across 1 companies, notably Protagonist Therapeutics, Inc. Aggregated, 2 filings have been logged. The latest transaction was disclosed on 15 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
07,500 shares0
Common Stock
SEC:0001104659-22-024841·
07,500 shares0
Common Stock
SEC:0001104659-22-024841:0·
2 of 2 declarations
About Kalkofen Donald A.
Donald A. Kalkofen is Chief Financial Officer at Protagonist Therapeutics, Inc. He is responsible for the financial management of the company, overseeing accounting and financial operations.
